Literature DB >> 11509828

Urinary excretion of aquaporin-2 water channel during pregnancy.

M Buemi1, R D'Anna, G Di Pasquale, F Floccari, A Ruello, C Aloisi, I Leonardi, N Frisina, F Corica.   

Abstract

BACKGROUND: In healthy primiparas the total body water content increases by about 8 liters within the last trimester, with a consequent reduction in plasma arginine-vasopressin (AVP) levels. The aim of the present study was to investigate the effect of normal pregnancy on urinary excretion of AQP2, a vasopressin sensitive water channel.
METHODS: Forty-five healthy pregnant primiparas (specify mean age and range) with a physiological single-fetus pregnancy were studied during weeks 12, 24 and 36 of pregnancy and then for 3 to 5 days postpartum. The control group consisted of 14 age-matched women in the early follicular phase of the menstrual cycle (day 5 or 6). The behavior of plasma AVP, ANP, oxytocin, urinary 6-keto-PGF1alpha (a metabolite of prostacyclin) and urinary AQP-2 excretion were evaluated in all subjects.
RESULTS: Plasma ANP and oxytocin, and urinary AQP-2 and 6kPGF1alpha excretion increased during all three trimesters, with the highest peaks at the 36(th) week. In the postpartum period, these values markedly decreased. No statistically significant changes were found in plasma AVP levels throughout the study period.
CONCLUSIONS: Our findings suggest that a non-AVP factor present in pregnancy plays a role in the control of the excretion of AQP-2 water channels. Copyright 2001 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509828     DOI: 10.1159/000047807

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  10 in total

Review 1.  Aquaporins in kidney pathophysiology.

Authors:  Yumi Noda; Eisei Sohara; Eriko Ohta; Sei Sasaki
Journal:  Nat Rev Nephrol       Date:  2010-01-26       Impact factor: 28.314

Review 2.  Dynamic regulation and dysregulation of the water channel aquaporin-2: a common cause of and promising therapeutic target for water balance disorders.

Authors:  Yumi Noda
Journal:  Clin Exp Nephrol       Date:  2013-10-16       Impact factor: 2.801

3.  The impact of maternal protein restriction during rat pregnancy upon renal expression of angiotensin receptors and vasopressin-related aquaporins.

Authors:  Ruth Cornock; Simon C Langley-Evans; Ali Mobasheri; Sarah McMullen
Journal:  Reprod Biol Endocrinol       Date:  2010-08-31       Impact factor: 5.211

4.  Molecular mechanisms of clinical concentrating and diluting disorders.

Authors:  Robert W Schrier
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

Review 5.  Aquaporin water channels in the mammary gland: from physiology to pathophysiology and neoplasia.

Authors:  Ali Mobasheri; Richard Barrett-Jolley
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-12-13       Impact factor: 2.673

Review 6.  Urine Aquaporin-2: A Promising Marker of Response to the Arginine Vasopressin Type-2 Antagonist, Tolvaptan in Patients with Congestive Heart Failure.

Authors:  Teruhiko Imamura; Koichiro Kinugawa
Journal:  Int J Mol Sci       Date:  2016-01-14       Impact factor: 5.923

Review 7.  Aquaporins in Urinary Extracellular Vesicles (Exosomes).

Authors:  Sayaka Oshikawa; Hiroko Sonoda; Masahiro Ikeda
Journal:  Int J Mol Sci       Date:  2016-06-17       Impact factor: 5.923

8.  Release of urinary aquaporin-2-bearing extracellular vesicles is decreased in pregnant Japanese Black cattle.

Authors:  Thitaporn Sinlapadeelerdkul; Hiroko Sonoda; Kazuyuki Uchida; Go Kitahara; Masahiro Ikeda
Journal:  J Vet Med Sci       Date:  2019-09-27       Impact factor: 1.267

Review 9.  Hormones and hemodynamics in pregnancy.

Authors:  Oleksandra Tkachenko; Dmitry Shchekochikhin; Robert W Schrier
Journal:  Int J Endocrinol Metab       Date:  2014-04-01

10.  Predictive Value of Urinary Aquaporin 2 for Acute Kidney Injury in Patients with Acute Decompensated Heart Failure.

Authors:  Ming-Jen Chan; Yung-Chang Chen; Pei-Chun Fan; Cheng-Chia Lee; George Kou; Chih-Hsiang Chang
Journal:  Biomedicines       Date:  2022-03-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.